Beschreibung:
<jats:sec><jats:title>Purpose:</jats:title><jats:p> To evaluate the long-term efficacy of hydrophilic and lipophilic statin therapy for cardiovascular outcomes in Asian diabetic patients. </jats:p></jats:sec><jats:sec><jats:title>Method:</jats:title><jats:p> Newly diagnosed cases of type 2 diabetes during the period from January 2000 to December 2011 were divided into 2 cohorts on the basis of their statin use, namely hydrophilic statin and lipophilic statin. We used Cox proportional hazard regression models to analyze the risks of cardiovascular outcomes. </jats:p></jats:sec><jats:sec><jats:title>Result:</jats:title><jats:p> In this study, 12 896 patients used statin, including 4259 patients using hydrophilic statin and 8637 patients using lipophilic statin. With 12-year follow-up, higher incidence rate of coronary artery disease and stroke was noted in the lipophilic statin use instead of hydrophilic statin use. </jats:p></jats:sec><jats:sec><jats:title>Conclusion:</jats:title><jats:p> According to our long-term cohort study, hydrophilic statin use may be a better choice than lipophilic statin to reduce cardiovascular events in Asian diabetic patients. </jats:p></jats:sec>